// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

PrEP use, access and perception of risk in a UK sexual health clinic outside London: findings from the challenges and opportunities of PreP (CHOP) study

Lindsey Harryman - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

PEP in the city – a new way of delivering post-exposure prophylaxis from the Emergency Department

Elizabeth Okecha - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Methadone hydrochloride

A dangerous waiting game? Are patients coming to harm whilst awaiting PrEP?

Molly Stewart - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

PEPSE management – Are we meeting the standards?

Clare McCartney - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

emtricitabine

Case study: a 13 year old boy’s post exposure prophylaxis was stopped prematurely due to Raltegravir induced thrombocytopenia

Sarah Stockwell - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Thrombocytopenia

MK0518

Introduction of the first virtual PrEP Service in Scotland

Rona MacDonald - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Review of managing HIV infected pregnant women – an audit against BHIVA guidelines

Amy Berry - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Should hyperproteinaemia be specifically recommended as an indication for HIV testing, in order to further improve 90–90-90?

Nana Anim-Addo - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evaluating trends in new HIV diagnoses over 9 years in an inner-London HIV clinic

Jonathan Tugbobo - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of user characteristics and testing outcomes between a national online service targeting high risk populations and local online services in the same areas

Alicia Thornton - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Trends in HIV testing and diagnosis in UK general practice from 2005–2016

Thomas Hartney - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acceptability of i-reader mobile camera technology in an online HIV self-testing pathway

Karen Lloyd - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Characteristics of service users diagnosed with HIV infection via a large online sexual health service (SHS)

Kaywaan Khan - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Human immunodeficiency virus infection

N/A

HIV testing outcomes of persons using a large urban online sexual health service (SHS)

Kaywaan Khan - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Feasibility and acceptability of receiving reactive HIV self-test results at home within an online clinical pathway

Karen Lloyd - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

HIV testing in patients diagnosed with community acquired pneumonia (CAP)

Christopher Roberts - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implementation of HIV testing for patients with indicator conditions at a district general hospital

George Woodger - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lymphomas

N/A

Can pre-test discussion for blood-borne virus screening be simplified further?

Natalia Sterling - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Exploring impact of a social impact bond on a hospital’s ability to engage PLHIV in treatment and care

Stephen Hindle - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Knowledge of U = U: reported impact on HIV stigma and HIV testing in sexual health clinic attendees

Naomi Adams - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved